P536: VALUE OF MEASURABLE RESIDUAL DISEASE BY MULTIPARAMETRIC FLOW CYTOMETRY IN NON-PROMYELOCYTIC ACUTE MYELOID LEUKEMIA. REAL WORLD EVIDENCE. (23rd June 2022) - Gimenez Conca, A. D.; Gonzalez, J.; Rivas, M. M.; Navickas, A.; Fernandez, I.; Rey, I.; Dick, H.; Cranco, S.; Moirano, M.; Ferrari, L.; Clavijo, M.; Suero, A.; et al.